Minimally invasive thoracic surgery is the development trend of thoracic surgery in the 21st century. The advantages of thoracoscopic lobectomy are mainly reflected in the following aspects: 1, small surgical incision with small trauma, generally using three keyhole-sized incisions, (one of which is slightly about 4-5 cm for removing the lobe), aesthetically pleasing, and more conducive to the patient’s acceptance of the surgery. 2.The magnification imaging system enables the operator to operate the surgical instruments more finely and accurately. 3.Less intraoperative bleeding, reduce blood loss to the trauma of the body, really arrive at good blood protection, and generally very little blood transfusion. 4.Light pain, small incision, natural gap into the chest cavity, no use of rib spacers. 5.The postoperative pulmonary function is less impaired, which improves the scope of application of the operation. It provides surgical treatment opportunity for a part of early stage lung cancer patients with advanced age and high risk factors. 6.Better quality of life in the long term. Shortened hospital stay and low incidence of postoperative complications can improve the survivability of elderly patients and high-risk patients after discharge from hospital. Thoracoscopic lobectomy is a reasonable choice for surgically resectable patients as long as it does not violate the standards of tumor treatment and the principles of thoracic surgical resection. With the improvement of surgical techniques, the current indications for surgery are: 1.Stage I, early peripheral lung cancer with a diameter of 5 cm or less. 2, Some stage II and some IIIa lung cancer patients. 3.Patients with some benign diseases, such as: bronchiectasis, benign lung tumors, lung cysts, etc. The current surgical methods of minimally invasive lobectomy and radical lung cancer resection include: total thoracoscopic lobectomy, segmental lung resection, sleeve lobectomy, combined chest wall resection, total lung resection, etc.